title: Myelofibrosis as the initial presentation of donor-derived myelodysplastic syndrome/AML: failure of a lasting response to a second allogeneic transplant from the original donor.
authors.forename: R J
authors.initials: RJ
authors.lastname: Cutting
authors.forename: E
authors.initials: E
authors.lastname: Welch
authors.forename: J
authors.initials: J
authors.lastname: Channer
authors.forename: Y
authors.initials: Y
authors.lastname: Ezaydi
authors.forename: P
authors.initials: P
authors.lastname: Talley
authors.forename: J T
authors.initials: JT
authors.lastname: Reilly
authors.forename: J A
authors.initials: JA
authors.lastname: Snowden
mesh_terms: D000328:Adult; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy; D009190:Myelodysplastic Syndromes / Q000175:diagnosis / Q000209:etiology*; D055728:Primary Myelofibrosis / Q000175:diagnosis / Q000209:etiology*; D014019:Tissue Donors; D019172:Transplantation Conditioning